NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 137 filers reported holding NEOGENOMICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,138,648 | -40.6% | 92,573 | -22.4% | 0.03% | -42.0% |
Q2 2023 | $1,915,978 | -43.6% | 119,227 | -38.9% | 0.05% | -46.2% |
Q1 2023 | $3,399,390 | +597.2% | 195,255 | +270.0% | 0.09% | +564.3% |
Q4 2022 | $487,567 | +95.0% | 52,767 | +82.0% | 0.01% | +55.6% |
Q3 2022 | $250,000 | -59.5% | 28,989 | +60.2% | 0.01% | -76.3% |
Q4 2021 | $617,000 | -30.5% | 18,091 | -1.7% | 0.04% | -53.1% |
Q1 2021 | $888,000 | +181.9% | 18,405 | +214.3% | 0.08% | +145.5% |
Q4 2020 | $315,000 | -48.0% | 5,856 | -64.4% | 0.03% | -15.4% |
Q3 2020 | $606,000 | +87.6% | 16,434 | -2.6% | 0.04% | +39.3% |
Q3 2019 | $323,000 | -67.3% | 16,875 | -65.0% | 0.03% | -60.0% |
Q1 2019 | $987,000 | +2.9% | 48,248 | -36.6% | 0.07% | +16.7% |
Q4 2018 | $959,000 | +165.7% | 76,060 | +71.7% | 0.06% | +140.0% |
Q1 2018 | $361,000 | +102.8% | 44,301 | +96.7% | 0.02% | +8.7% |
Q1 2017 | $178,000 | +7.2% | 22,520 | +8.8% | 0.02% | +4.5% |
Q2 2016 | $166,000 | – | 20,696 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |